What Vygon does

Vygon is a French-headquartered, privately held medical device manufacturer founded in 1962 that designs and produces sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, regional anesthesia and pain management, respiratory care, surgical consumables, and urinary care. Its portfolio spans acute dialysis catheters, central and peripheral venous catheters, PICC lines, midlines, implantable ports, neonatal-specific feeding systems (Nutrisafe2, celebrating a 20-year heritage in 2026), ISO 80369-3 / 80369-6 compliant safety connectors (ENFit/Nutrifit, NRFit), nerve block and epidural delivery systems, endotracheal tubes and Boussignac CPAP accessories, and the MostCare Up hemodynamic monitor. The company invests approximately 5% of revenue into R&D through a 60-person team operating across four development centers in France and Germany, supported by a portfolio of 183 globally filed patents.

Vygon produces roughly 210 million medical devices per year from predominantly European factories in Écouen (SIPV, SIPA), Belgium (Dimequip), and Germany, and sells through 26 wholly-owned subsidiaries and complementary distribution partners serving healthcare facilities in over 120 countries. Revenue is generated almost entirely through B2B hardware sales of single-use devices under quote-based, multi-year procurement contracts negotiated with hospitals, clinical departments, and group purchasing organizations; no consumer-facing pricing is published. The company employs 2,783 people globally and is led by CEO Ludovic Richard-Vitton and Chairman Stéphane Regnault, with CFO Anne Najaint and a broader executive team overseeing strategy, manufacturing, operations, and international deployment.

FY2025 reported revenue was €423 million, reflecting the cumulative scale of organic expansion and a steady M&A track record (Perouse Medical 2015, Advanced Perfusion Diagnostics 2020, Macatt Medica 2022, Stiletto 2026). Co-development partnerships with Institut Curie (oncology safety devices, Qimono line) and Carmat (artificial heart connectivity) extend the company's specialization into adjacent safety-critical niches, while management rotations in the UK and German subsidiaries during 2026 signal continued investment in commercial leadership across its two largest European markets.

Name

Vygon

Legal name

Vygon, Société Anonyme Simplifiée au capital de 19 463 088 €

Website

https://vygon.com

Company type

Private

Founded year

1962

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vygon is a French-headquartered, privately held medical device manufacturer (founded 1962) that designs and produces sterile single-use devices across vascular access, enteral feeding, anesthesia, respiratory, surgical, urinary, and monitoring categories, serving hospitals in over 120 countries via 26 subsidiaries.

Ownership category

akta.pro rank

Product category

Single-Use Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industries

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK), Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)

Keywords

• Single-use medical devices
• Vascular access catheters
• Enteral feeding systems
• Regional anesthesia devices
• Sterile medical devices

Headquarters

HQ city

Écouen

HQ country

France

HQ region

Europe

Offices11 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Vygon generates revenue primarily through the sale of sterile single-use and electronic medical devices across multiple therapeutic categories including vascular access, enteral feeding, respiratory, surgical, and monitoring solutions. Products are sold directly through subsidiaries and distribution networks to healthcare facilities worldwide.
2. Product Portfolio Diversification: Revenue streams span seven major product categories: Vascular, Enteral, Monitoring, Nervous, Respiratory, Surgery, and Urinary, providing diversified revenue across therapeutic areas and reducing dependency on any single product line.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Vygon designs, manufactures, and sells sterile single-use and electronic medical devices organized into seven therapeutic categories: vascular access, enteral feeding, hemodynamic monitoring, nervous system (regional anesthesia), respiratory, surgery, and urinary care. The company produces over 210 million medical devices annually from European manufacturing facilities and serves healthcare professionals in more than 120 countries through 26 subsidiaries. Products are targeted at hospital systems and clinical departments for use in patient care from neonates to adults.

Product overview

Vygon designs and manufactures sterile single-use and electronic medical devices. The company operates as a global medical device manufacturer with a diversified product portfolio organized into seven core categories: Vascular Access (including acute dialysis catheters, CVCs, PICC lines, midlines, implantable ports, and infusion therapy), Enteral Feeding (with ENFit/Nutrifit safety systems and Nutrisafe2 for neonates), Hemodynamic Monitoring (MostCare Up), Nervous System/Anesthesia products, Respiratory/Ventilation products, Surgery supplies, and Urinary care products. Vygon produces over 210 million medical devices annually across its European-focused manufacturing sites, with 26 subsidiaries serving customers in over 120 countries. The company emphasizes product safety, innovation (183 patents filed), and specialized solutions for vulnerable patient populations including neonates and pediatrics.

Differentiator

Problem solved

Functional benefit

Brands

• Nutrisafe2: Safety enteral feeding system for neonates and preemies, celebrating 20th anniversary in 2026
• MostCare Up
• ENFit / Nutrifit
• Stiletto
• VascuFirst
• Campus Vygon

Products and services

• Vascular Access Products A comprehensive range of sterile single-use devices for short, medium, and long-term access to the peripheral and central vascular system, serving patients from newborns to adults. Includes acute dialysis catheters, adult and pediatric central venous catheters (CVC), arterial catheters, PICC lines, midlines, implantable ports, Huber needles, peripheral IV catheters, tunneled CICC, securement devices, dressings, stimulating catheters, and IV accessories for oncology.
• Enteral Feeding Products Feeding tubes and systems for patients from neonates to adults, including safety connectors (ENFit/Nutrifit), non-safety feeding systems, Nutrisafe2 systems for neonates/preemies, and feeding pumps and sets. Designed for safe enteral nutrition delivery and prevention of misconnections.
• MostCare Up Hemodynamic monitoring solution for real-time patient management, providing monitoring capabilities for hemodynamic assessment of the patient.
• Nervous System (Regional Anesthesia) Products Products for regional anesthesia delivery and pain management, including epidural anesthesia, spinal anesthesia, plexus and peripheral nerve blocks. Includes accessories for regional anaesthesia, cryotherapy, PCA (Patient Controlled Analgesia), NRFit secure range, standard LUER range, and Vysets custom sets.
• Respiratory Products Products for both invasive ventilation (endotracheal tubes from neonates to adults, suction catheters, mucus extractors) and non-invasive ventilation (oxygen therapy, Boussignac CPAP accessories). Also includes connectors, facial masks, intubation accessories, thoracic drainage, tracheal suction tubes, and protected bronchial sampling.
• Surgery Products Surgical consumables for operating room procedures including drapes, gowns, patient asepsis products, cyanoacrylate glue for wound closure, surgical suction and wound drainage systems, suture materials, and hygiene products.
• Urinary Care Products Products for urinary catheterization and monitoring, including vesical catheters, hourly diuresis monitoring systems, and vesical lavage equipment.
• Nutrisafe2 Safety Enteral Feeding System A safety enteral feeding system specifically designed for neonates and premature babies with dedicated medical devices addressing the unique physiological needs of neonatal patients due to their tiny size and immaturity. Features specialized connectors to prevent misconnections.
• ENFit / Nutrifit Feeding Systems Safety enteral feeding connectors designed to prevent misconnections with other medical devices, meeting ISO 80369-3 standard for adult patients. ENFit is the global standard for enteral nutrition connections.
• Stiletto Extended-Dwell Catheter A next-generation extended-dwell catheter acquired by Vygon in February 2026. Designed for smooth, guidewire-free insertion and enhanced patient comfort, strengthening Vygon's vascular access leadership.

Quantifiable outcome

• 210 million medical devices produced annually from European manufacturing
• +2 more outcomes

Named customers3 records

Segments8 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Institut CuriecoreStrategic or Co-development PartnerStrategic collaboration with Institut Curie to develop new safety standards for oncology devices. This partnership resulted in the creation of the Qimono product line, which provides safety devices protecting medical staff exposed to cytotoxic drug toxicity during oncology treatments.
• CarmatminorStrategic or Co-development PartnerPartnership with Carmat to develop high-precision connectivity solutions for artificial heart devices. Vygon contributes its expertise in medical device connectors and manufacturing to complement Carmat's artificial heart technology.

Scale indicators9 records

Recent moves7 records

Expansion highlights3 records

Broad incumbents

• Becton Dickinson (BD): BD is a broad-line medical device incumbent competing with Vygon in vascular access (PICC/midlines), surgical disposables, and respiratory products, with deeper U.S. footprint and broader GPO contracts.
• Medline Industries: Medline is a large private medical supply manufacturer with adjacent categories including surgical drapes/gowns, vascular access accessories, and urinary care, competing with Vygon's surgical and consumables lines primarily through U.S. distribution.
• B. Braun Melsungen: B. Braun is a larger diversified medical device incumbent with substantial overlap in IV therapy, regional anesthesia, vascular access, and infusion systems, competing against Vygon across most of its seven therapeutic categories.
• Fresenius Kabi: Fresenius Kabi is a broad medical device and infusion therapy incumbent overlapping Vygon's vascular access, enteral nutrition, and infusion product lines, particularly in European hospital channels.

Direct peers

• Teleflex: Teleflex is a direct peer across vascular access, anesthesia, and respiratory single-use devices, mirroring Vygon's portfolio in catheters, epidural/spinal anesthesia, and airway management with comparable enterprise sales motion to hospitals globally.
• ICU Medical: ICU Medical (post Smiths Medical integration) directly overlaps Vygon's vascular access, IV therapy, and enteral feeding categories, serving the same hospital customers with similar disposable medical device portfolios and GPO-style procurement.
• Cook Medical: Cook Medical directly competes with Vygon in vascular access and enteral feeding devices, particularly catheters and specialty access products, with similar hospital-focused enterprise sales motion.
• Smiths Medical (now ICU Medical): Smiths Medical (acquired by ICU Medical in 2024) historically overlapped directly with Vygon in vascular access, enteral feeding, and respiratory/anesthesia disposables with comparable product breadth and hospital sales channels.

Emerging players

• Amsino International: Amsino is an emerging player in single-use medical devices including urinary catheters, IV therapy, and enteral feeding products, providing lower-cost competition to Vygon particularly in non-European markets.
• GBUK Group: GBUK Group is a UK-based specialist in enteral feeding and vascular access devices with partial overlap to Vygon's Nutrisafe2 and ENFit portfolios, competing primarily in the UK hospital market segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@VygonGroupMedicalDevices
• Facebookm.facebook.com/profile.php/?id=100064840091500&name=xhp_nt__fb__action__open_user
• LinkedInlinkedin.com/company/vygon
• Instagraminstagram.com/vygongroup

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries17 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vygon